Papillomaviridae

• 

  Subject Areas on Research

  • A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin. 
  • A comparison of commercially available probes for in situ hybridization to human papillomavirus DNA. 
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. 
  • A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. 
  • A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients. 
  • A research for the relationship between human papillomavirus and human uterine cervical carcinoma. II. Molecular genetic and ultrastructural study on the transforming activity of recombinant retrovirus containing human papillomavirus type 16 subgenomic sequences. 
  • Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. 
  • Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. 
  • Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • Anal-rectal cytology: a review. 
  • Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients. 
  • Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. 
  • Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma. 
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. 
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines. 
  • Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. 
  • Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. 
  • Cervical-vaginal and intraanal human papillomavirus infection of young girls with external genital warts. 
  • Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. 
  • Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. 
  • Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening. 
  • Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness of a potential vaccine for human papillomavirus. 
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. 
  • Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? 
  • Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. 
  • Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. 
  • Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer. 
  • Different strokes for different folks: new paradigms for staging oropharynx cancer. 
  • Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma. 
  • End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. 
  • Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. 
  • Evaluation of sexually abused and nonabused young girls for intravaginal human papillomavirus infection. 
  • Gene Editing: A New Tool for Viral Disease. 
  • HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. 
  • Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. 
  • Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program. 
  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. 
  • Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. 
  • Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. 
  • Human papillomavirus in early laryngeal carcinoma. 
  • Human papillomavirus infection. Frequency and association with cervical neoplasia in a young population. 
  • Human papillomavirus testing for precancerous lesions of the cervix. 
  • Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. 
  • Human papillomavirus types important in progression of inverted papilloma. 
  • Immortalization of a human prostate stromal cell line using a recombinant retroviral approach. 
  • In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. 
  • Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. 
  • Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. 
  • Knowledge about human papillomavirus among adolescents. 
  • Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. 
  • Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31. 
  • Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. 
  • Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. 
  • Methods for analyzing bovine papilloma virus-based calmodulin expression vectors. 
  • Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution. 
  • Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. 
  • Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. 
  • Perinatal transmission and maternal risks of human papillomavirus infection. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Presence of human papillomavirus predicts recurrence of inverted papilloma. 
  • Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. 
  • Prevalence of sexual abuse in children with genital warts. 
  • Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. 
  • RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. 
  • Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes. 
  • Re: Detection of human papillomavirus in squamous neoplasm of the penis. 
  • Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. 
  • Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. 
  • Short birth intervals and uterine cervical cancer risk in Jamaican women. 
  • Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients. 
  • Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. 
  • Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis. 
  • The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma. 
  • The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network. 
  • Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Virus-induced experimental brain tumors and putative associations of viruses with human brain tumors: a review. 
  • [Sequence analysis of the late region of human papillomavirus type 6 genome] 
  • p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Cohen, Seth Morris, Associate Professor of Surgery, Surgery, Head and Neck Surgery and Communication Sciences
  • Esclamado, Ramon Mitra, Richard Hall Chaney, Sr. Professor of Otolaryngology, Surgery, Head and Neck Surgery and Communication Sciences